10-Q/A

AMENDMENT TO FORM 10-Q

Company: Vistagen Therapeutics, Inc.
Filed: May 1, 2017
Period of Report: December 31, 2016
Accession Number: 0001654954-17-003815

View Document ↗ View on SEC.gov ↗